EHF (gene)

EHF (gene)

The EHF gene, also known as ETS homologous factor, is a gene that is located on the 11th chromosome in humans. It is a member of the ETS family of transcription factors and is involved in a variety of functions including cellular development, cell proliferation, and apoptosis.^[1]

Function

The EHF gene encodes a protein that functions as a transcriptional repressor and has been shown to downregulate the expression of genes involved in cell growth and proliferation. It is also involved in the regulation of epithelial cell differentiation and has been implicated in the development of prostate cancer and asthma.^[2]

Clinical significance

Mutations in the EHF gene have been associated with a variety of diseases. For example, a mutation in this gene has been linked to an increased risk of prostate cancer. Additionally, variations in the EHF gene have been associated with susceptibility to asthma and other respiratory diseases.^[3]

References

↑ , Genomic and biochemical insights into the specificity of ETS transcription factors, Annual Review of Biochemistry, 2011, Vol. 80, pp. 437–71, DOI: 10.1146/annurev.biochem.79.081507.103945, PMID: 21456944,
↑ , Defining ETS transcription regulatory networks and their contribution to breast cancer progression, Journal of Cellular Biochemistry, 2007, Vol. 102(Issue: 3), pp. 549–59, DOI: 10.1002/jcb.21287, PMID: 17226767,
↑ , Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population, Nature Genetics, 2012, Vol. 44(Issue: 12), pp. 1222–6, DOI: 10.1038/ng.2438, PMID: 23104006,

   This article is a medical stub. You can help WikiMD by expanding it!

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP-1 injections from $125.

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.

NYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC

Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

[1] , Genomic and biochemical insights into the specificity of ETS transcription factors, Annual Review of Biochemistry, 2011, Vol. 80, pp. 437–71, DOI: 10.1146/annurev.biochem.79.081507.103945, PMID: 21456944,

[2] , Defining ETS transcription regulatory networks and their contribution to breast cancer progression, Journal of Cellular Biochemistry, 2007, Vol. 102(Issue: 3), pp. 549–59, DOI: 10.1002/jcb.21287, PMID: 17226767,

[3] , Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population, Nature Genetics, 2012, Vol. 44(Issue: 12), pp. 1222–6, DOI: 10.1038/ng.2438, PMID: 23104006,

[1]

[2]

[3]